 The Roche Investor Relations team would like to invite you to the Roche Diagnostics Investor Day that will take place in London on Wednesday, 22 May 2024, starting at 12:00 BST local time and will finish at 15:30 BST with a reception. The Roche Diagnostics Investor Day will address the following topics:
Presenters include: Matt Sause, CEO Roche Diagnostics Alan Hippe, Chief Financial and IT Officer Palani Kumaresan, Global Head of Roche Diagnostics Solutions (RDS) Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems Jochen Berchtold, Franchise Lead Insulin Therapy Solutions Ildiko Amann-Zalan, Head of Research & Development Roche Diagnostics Solutions Nico Michel, Lifecycle Leader Infectious Diseases - Molecular Lab Olivier Gillieron, Lifecycle Leader Cardiometabolic and Neurology Meeting information: Date/Time (BST): Wednesday, 22 May 2024 12:00 - 13:00 Registration and lunch 13:00 - 15:30 Presentations & Q&A 15:30 - 16:15 Refreshments with Roche Management Team Venue Convene (formerly etc venues) 133 Houndsditch London EC3A 7BX > map To register for the event, please follow this > link (passcode: Dia2024). The slides will be available for download at 12:00 BST on the day of the event. > click here Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration required). Please pre-register for the webinar here*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com . A replay of the event will be available via > ir.roche.com *privacy notice Best regards, | |
| Bruno Eschli Head of Investor Relations | Birgit Masjost Investor Relations Officer |
| Roche Investor Relations | |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | |
| Investor Relations North America | |
| Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
get the latest news and updates to your inbox.